XML 99 R85.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Subsequent Events (Details) - USD ($) |  |  | 12 Months Ended |
--- | --- | --- | --- | ---
Dec. 01, 2017 | Nov. 01, 2017 | Oct. 31, 2017 | Sep. 30, 2017
2017 Term Loan Agreement [Member] | Base Rate [Member] | Minimum [Member] |  |  |  |
Subsequent Event [Line Items] |  |  |  |
Debt Instrument, Basis Spread on Variable Rate |  |  | 0.00% |
2017 Term Loan Agreement [Member] | Base Rate [Member] | Maximum [Member] |  |  |  |
Subsequent Event [Line Items] |  |  |  |
Debt Instrument, Basis Spread on Variable Rate |  |  | 0.75% |
2017 Term Loan Agreement [Member] | London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member] |  |  |  |
Subsequent Event [Line Items] |  |  |  |
Debt Instrument, Basis Spread on Variable Rate |  |  | 1.00% |
2017 Term Loan Agreement [Member] | London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member] |  |  |  |
Subsequent Event [Line Items] |  |  |  |
Debt Instrument, Basis Spread on Variable Rate |  |  | 1.75% |
Line of Credit [Member] | Bridge Loan [Member] |  |  |  |
Subsequent Event [Line Items] |  |  |  |
Face amount |  |  |  | $ 1,100,000,000
Subsequent Event [Member] | Senior Unsecured Term Loan Agreement [Member] | Senior Unsecured Term Loan Agreement [Member] |  |  |  |
Subsequent Event [Line Items] |  |  |  |
Face amount |  | $ 1,425,000,000.000 |  |
Debt Instrument, Term |  | 5 years |  |
Subsequent Event [Member] | Teva Pharmaceuticals Industries LImited [Member] |  |  |  |
Subsequent Event [Line Items] |  |  |  |
Business Acquisition, Effective Date of Acquisition |  | Nov. 01, 2017 |  |
Business Combination, Consideration Transferred |  | $ 1,100,000,000 |  |
Subsequent Event [Member] | Paragon Vision Sciences [Member] |  |  |  |
Subsequent Event [Line Items] |  |  |  |
Business Combination, Consideration Transferred | $ 80,000,000 |  |  |

X
- Definition Date when the acquirer obtains control of the acquiree, in CCYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 25 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=73531572&loc=d3e845-128460 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Acquisition Date -URI http://asc.fasb.org/extlink&oid=6919109 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 25 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=73531572&loc=d3e848-128460 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Percentage points added to the reference rate to compute the variable rate on the debt instrument. + References No definition available. + Details
Name: | us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Face (par) amount of debt instrument at time of issuance. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 55 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399 + Details
Name: | us-gaap_DebtInstrumentFaceAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | us-gaap_DebtInstrumentTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. + References No definition available. + Details
Name: | us-gaap_SubsequentEventLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_LongtermDebtTypeAxis=coo_TwoThousandSeventeenTermLoanAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_VariableRateAxis=us-gaap_BaseRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=coo_SeniorUnsecuredTermLoanAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=coo_TevaPharmaceuticalsIndustriesLImitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=coo_ParagonVisionSciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |